A new review of major clinical studies presented at a global hematology meeting shows that Yescarta®, a CAR T-cell therapy, continues to help people with relapsed or refractory large B-cell …
© Copyright by FLORIDA NEWS AGENCY (A Digital Media Brand owned by AMAZON MEDIA LLC).